**Author details**

Irina Bobolea1\* and Luis Alejandro Pérez de Llano2

\*Address all correspondence to: ibobolea@gmail.com

1 Allergy Department, Hospital 12 de octubre Institute for Health Research (i+12), Madrid, Spain

2 Head of the Pulmonology Department, Hospital Lucus Augusti, Lugo, Spain

### **References**


[6] Miravitlles M, Soler-Cataluna JJ, Calle M, Molina J, Almagro P, Quintano JA et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. *Arch Bronconeumol* 2012; 48(7): 247–257.

**9. Conclusions**

212 Asthma - From Childhood Asthma to ACOS Phenotypes

patients.

Spain

**References**

07:1053–1060.

170.

**Author details**

Irina Bobolea1\* and Luis Alejandro Pérez de Llano2

and asthma. *Respir Res* 2011; 12:127.

\*Address all correspondence to: ibobolea@gmail.com

ACOS is the coincidence of asthma and COPD in the same individual. Prospective studies are required to analyze the underlying inflammatory mechanisms in this entity. So we think that longitudinal studies are required to validate the diagnostic criteria and identify biomarkers of the disease. It also remains to be determined if it has different prognostic and therapeutic implications. If so, perhaps in the future, ACOS will be considered a distinct endotype of chronic obstructive airway disease. There is also a lack of studies to further clarify the best therapeutic options for patients with ACOS. At this moment, it seems reasonable to consider the combination of an ICS and a long-acting β-agonist as the first-choice therapy for these

1 Allergy Department, Hospital 12 de octubre Institute for Health Research (i+12), Madrid,

[1] Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its

[2] Hardin M, Silverman EK, Barr RG, et al. The clinical features of overlap between COPD

[3] Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPDasthma phenotype. Focus on physical activity and health status. *Respir Med* 2013;

[4] Pleasants RA, Ohar JA, Croft JB, et al. Chronic obstructive pulmonary disease and asthma – patient characteristics and health impairment. *COPD* 2014; 11:256–266.

[5] Rhee CK, Yoon HK, Yoo KH, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. *COPD* 2014; 11:163–

2 Head of the Pulmonology Department, Hospital Lucus Augusti, Lugo, Spain

features and how important is it? *Thorax* 2009; 64:728–735.


[32] Weiner P, Weiner M, Azgad Y, et al. Inhaled budesonide therapy for patients with stable COPD. *Chest* 1995; 108(6):1568–1571.

[19] Bobolea I, Barranco P, Del Pozo V, et al. Sputum periostin in patients with different

[20] Wagener AH, de Nijs SB, Lutter R, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. *Thorax*

[21] Kankaanranta H, Harju T, Kilpeläinen M, et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finish guidelines. *Basic Clin Pharma‐*

[22] Kovlizek V, Chlumsky J, Zindr V, et al. Chronic obstructive pulmonary disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. *Biomed Pap*

[23] Golpe R, Sanjuán López P, Cano Jiménez E, et al. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco

[24] Miravitlles M, Huerta A, Fernández-Villar JA, et al. Generic utilities in chronic ob‐ structive pulmonary disease patients stratified according to different staging systems.

[25] Miravitlles M, Alcázar B, Alvarez FJ, Bazús T, Calle M, Casanova C, et al. What pulmonologists think about the asthma-COPD overlap syndrome. *Int J Chron Obstruct*

[26] GEMA 4.0. Guía Española para el manejo del asma. 2015. Available at http://

[27] Andersen H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syn‐

[28] Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD

[29] Cosio BG, Soriano JB, López-Campos JL, et al. Defining the asthma-COPD overlap

[30] Magnussen H, Bugnas B, van Noord J, Schmidt P, Gerken F, Kesten S. Improvements with tiotropium in COPD patients with concomitant asthma. *Respir Med* 2008; 102:50–

[31] Kerstjens HA, Overbeek SE, Schouten JP, et al. Airways hyperresponsiveness, bron‐ chodilator response, allergy and smoking predict improvement in FEV1 during longterm inhaled corticosteroid treatment. Dutch CNSLD Stud Group. *Eur Respir J* 1993;

severe asthma phenotypes. *Allergy* 2015; 70(5):540–546.

*Med Fac Univ Palacky Olomouc Czech Repub*. 2013; 157:189–201.

drome of asthma and COPD. *Clin Respir J* 2013; 7(4):342–346.

predicts low quality of life. *J Asthma* 2011; 48(3):279–285.

syndrome in a COPD cohort. *Chest* 2016; 149(1): 45–52.

smoke. *Arch Bronconeumol*. 2014; 50:318–324.

*Health Qual Life Outcomes*. 2014; 12:120.

*Pulmon Dis* 2015; 10:1321–1330.

www.gemasma.com.

56.

6(6):868–876.

2015; 70(2): 115–120.

214 Asthma - From Childhood Asthma to ACOS Phenotypes

*col Toxicol* 2015; 116:291–307.

